Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ODTXOdyssey Therapeutics, Inc.

Nasdaq · CIK 0001882782
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts167

Identity from submissions API

NameOdyssey Therapeutics, Inc.
CIK0001882782
TickersODTX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN863384382
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(212) 841-1000
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
51 SLEEPER STREET
BOSTON
MA
02210
MA
Mailing address
51 SLEEPER STREET
BOSTON
MA
02210
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

72 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002807 005-95704 261526261 34 11594
2026-11-04 10-Q 10-Q 0001193125-26-446208 001-43270 261520039 34 12562555 1 1
2026-11-04 8-K 8-K 2.02,9.01 0001193125-26-446174 001-43270 261519968 34 221055 1 1
2026-10-20 8-K 8-K 7.01,9.01 0001193125-26-425684 001-43270 261470488 34 21379229 1 1
2026-09-09 8-K 8-K 7.01,9.01 0001193125-26-385477 001-43270 261366239 34 18919761 1 1
2026-08-06 10-Q 10-Q 0001193125-26-335822 001-43270 261245373 34 12475768 1 1
2026-08-04 8-K 8-K 2.02,9.01 0001193125-26-331512 001-43270 261235383 34 203754 1 1
2026-06-23 8-K 8-K 7.01,9.01 0001193125-26-278581 001-43270 261109044 34 18164499 1 1
2026-06-17 10-Q 10-Q 0001193125-26-274290 001-43270 261099182 34 11981517 1 1
2026-06-17 8-K 8-K 2.02,9.01 0001193125-26-274291 001-43270 261099177 34 182849 1 1
2026-06-05 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001419 005-95704 261067309 34 11413
2026-05-18 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002044377-26-000002 005-95704 26995603 34 15359
2026-05-18 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001072613-26-000468 005-95704 26995355 34 174737
2026-05-18 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001999371-26-011002 005-95704 26993186 34 22385
2026-05-15 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-226695 005-95704 26987287 34 36651
2026-05-15 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0000950103-26-007273 005-95704 26985991 34 25496
2026-05-13 4 FORM 4 0001999371-26-010652 23507
2026-05-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-26-000417 9985
2026-05-12 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-26-000416 6651
2026-05-11 4 4 0001193125-26-217656 74738
2026-05-11 4 4 0001193125-26-217607 21832
2026-05-11 4 4 0001193125-26-217600 4513
2026-05-11 4 4 0001193125-26-217593 9570
2026-05-11 4 4 0001193125-26-217592 5271
2026-05-11 4 4 0001193125-26-217590 5299
2026-05-11 4 4 0001193125-26-217589 4620
2026-05-11 4 4 0001193125-26-217588 5281
2026-05-11 4 4 0001193125-26-217587 5498
2026-05-11 4 4 0001193125-26-217586 5244
2026-05-11 4 4 0001193125-26-217585 11672
2026-05-11 4 4 0001193125-26-217584 24065
2026-05-11 4 4 0001193125-26-217583 5492
2026-05-11 8-K 8-K 1.01,3.02,5.03,9.01 0001193125-26-216899 001-43270 26963676 34 414901 1 1
2026-05-11 S-8 S-8 0001193125-26-215197 333-295741 26960334 33 370951 1 1
2026-05-08 424B4 424B4 0001193125-26-214819 333-295141 26959243 33 71259814
2026-05-07 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001538 333-295141 26955840 33 1726
2026-05-07 3 3 0001193125-26-212887 21118
2026-05-07 3 3 0001193125-26-212881 25474
2026-05-07 3 3 0001193125-26-212880 18539
2026-05-07 3 3 0001193125-26-212866 17575
2026-05-07 3 3 0001193125-26-212865 20696
2026-05-07 3 3 0001193125-26-212860 31344
2026-05-07 3 3 0001193125-26-212859 18842
2026-05-07 3 3 0001193125-26-212857 19917
2026-05-07 3 3 0001193125-26-212852 31120
2026-05-07 3 3 0001193125-26-212851 169689
2026-05-07 3 3 0001193125-26-212847 26813
2026-05-07 3 3 0001193125-26-212842 27407
2026-05-07 3 3 0001193125-26-212841 17809
2026-05-07 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001999371-26-010245 12989
2026-05-07 3 3 0001193125-26-212840 21602
2026-05-07 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001999371-26-010243 3748
2026-05-07 3 3 0001193125-26-212837 17408
2026-05-07 3 3 0001193125-26-212828 17241
2026-05-07 S-1MEF S-1MEF 0001193125-26-212775 333-295677 26955639 33 284374 1 1
2026-05-07 CERT ODTX_8A_Cert_1882782.pdf 0001354457-26-000416 001-43270 26952525 34 564591
2026-05-05 8-A12B 8-A12B 0001193125-26-205798 001-43270 26941840 34 28051
2026-05-04 S-1/A S-1/A 0001193125-26-202398 333-295141 26934514 33 73480446 1 1
2026-04-17 S-1 S-1 0001193125-26-161514 333-295141 26871547 33 80566395 1 1
2026-04-03 DRS/A filename1.htm 0001193125-26-142305 377-09019 26838819 33 69366455
2026-03-16 DRS/A filename1.htm 0001193125-26-108608 377-09019 26757884 33 93496704
2026-02-06 DRS filename1.htm 0001193125-26-041396 377-09019 26608714 33 9931097
2025-12-04 D xslFormDX01/primary_doc.xml 06b 0001104659-25-118426 021-565797 251549127 33 15428
2025-06-09 RW RW 0001193125-25-137861 333-284332 251034527 NE 9799
2025-01-17 S-1 S-1 0001193125-25-008362 333-284332 25538353 33 19714626
2024-12-05 DRS/A filename1.htm 0000950123-24-012178 377-07486 241527795 33 15858530
2024-11-18 DRS/A filename1.htm 0000950123-24-012003 377-07486 241469525 33 15306301
2024-10-07 DRS filename1.htm 0000950123-24-009534 377-07486 241355978 33 11829102
2024-08-14 D/A xslFormDX01/primary_doc.xml 06b 0001882782-24-000001 021-499898 241205787 33 12484
2023-12-15 D xslFormDX01/primary_doc.xml 06b 0001882782-23-000001 021-499898 231490568 33 10745
2022-10-27 D xslFormDX01/primary_doc.xml 06b 0001882782-22-000002 021-462964 221335197 33 9607
2021-10-14 D xslFormDX01/primary_doc.xml 06b 0001882782-21-000001 021-417003 211323654 33 9216

Latest XBRL company facts

One latest value per concept from companyfacts (167 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 48.07M 2026-11-02 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
ffd NetFeeAmt NetFeeAmt USD 19,634.4 2026-05-08 S-8 2026-05-11 0001193125-26-215197
ffd TtlFeeAmt TtlFeeAmt USD 19,634.4 2026-05-08 S-8 2026-05-11 0001193125-26-215197
ffd TtlOfferingAmt TtlOfferingAmt USD 142.18M 2026-05-08 S-8 2026-05-11 0001193125-26-215197
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-05-08 S-8 2026-05-11 0001193125-26-215197
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-05-07 S-1MEF 2026-05-07 0001193125-26-212775
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 8.26M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD -115,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 12.31M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.27M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 13.86M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -985,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.09B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 7.94M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 16.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 8.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap AreaOfLand Area of Land sqft 45,632 2021-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap Assets Assets USD 438.10M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap AssetsCurrent Assets, Current USD 337.80M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 1.13M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 307.47M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 306.35M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 12.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 179,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 80.64M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 84.09M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 39.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 48.07M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 47.94M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap CommonStockValue Common Stock, Value, Issued USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -145.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 24.60M 2026-03-31 2026 Q1 10-Q 2026-06-17 0001193125-26-274290
us-gaap DeferredRevenueAdditions Deferred Revenue, Additions USD 99,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap Depreciation Depreciation USD 2.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 3.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -5.12 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -5.12 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 166,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 4.92M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 37,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 37,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 117,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 1.72M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 86,000 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-335822
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 1.72M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -602,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 29.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap Goodwill Goodwill USD 14.12M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap GoodwillForeignCurrencyTranslationGainLoss Goodwill, Foreign Currency Translation Gain (Loss) USD -208,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -144.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap IncomeTaxesPaid Income Taxes Paid USD 251,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 104,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 338,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -3.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD -1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 854,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 42,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap InterestIncomeOther Interest Income, Other USD 8.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 42,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap InvestmentIncomeAmortizationOfDiscount Investment Income, Amortization of Discount USD 225,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-335822
us-gaap LeaseCost Lease, Cost USD 6.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.101 2025-06-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap Liabilities Liabilities USD 62.33M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 438.10M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap LiabilitiesCurrent Liabilities, Current USD 26.10M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 245.36M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 60.99M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 1.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 289.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -133.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -117.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -144.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -144.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 7.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap OperatingExpenses Operating Expenses USD 151.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -151.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap OperatingLeaseCost Operating Lease, Cost USD 4.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 5.40M 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 300,000 2025-06-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 5.53M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 17.95M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap OperatingLeasePayments Operating Lease, Payments USD 5.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 16.14M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 2.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 839,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 4.43M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -1.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -9,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -1.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -449,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 143,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-06-17 0001193125-26-274290
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 246.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 838,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 50.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 11.80M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 288.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 113.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 302,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -144.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 18.49M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 4.63M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap RedeemableNoncontrollingInterestEquityPreferredCarryingAmount Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount USD 703.56M 2026-03-31 2026 Q1 10-Q 2026-06-17 0001193125-26-274290
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 110.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 3.45M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -712.25M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 278,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 278,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-06-17 0001193125-26-274290
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 100.00M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-06-17 0001193125-26-274290
us-gaap SegmentReportingOtherItemAmount SegmentReportingOtherItemAmount USD 23.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 16.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage pure 0.25 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested USD 100,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-06-17 0001193125-26-274290
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 126,825 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 13.02 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 39,725 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 15.44 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.037 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.042 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 35.02M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 700,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 92,140 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 135,921 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 4.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 17.42 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-335822
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 14.71 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 91.63M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 8.16M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 11.09 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 2.19M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 6.29 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 4.74 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 24.14 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 11.92 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 17.98 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 375.77M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 293,265 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 703.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 152,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap SubleaseIncome Sublease Income USD 243,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 413.59M 2026-03-31 2026 Q1 10-Q 2026-06-17 0001193125-26-274290
us-gaap VariableLeaseCost Variable Lease, Cost USD 2.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 28.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 28.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446208

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →